Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: CA262084
National Institutes of Health
Grant: 1R01CA262084-01
Novel noncanonical actions of CAR in human Liver
National Institutes of Health
Grant: 1UL1TR003098-01
Johns Hopkins Institute for Clinical and Translational Research
National Institutes of Health
Grant: 1R01GM121550-01A1
Function and Regulation of SLC13A5 in the Liver
NCI NIH HHS
Grant: R01 CA262084
NIGMS NIH HHS
Grant: R01 GM121550
NCATS NIH HHS
Grant: UL1 TR003098
FWCI
1.38
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals